384 related articles for article (PubMed ID: 18275908)
1. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
3. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
4. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
5. The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.
Gallant JP; Lima-Cordón RA; Justi SA; Monroy MC; Viola T; Stevens L
Infect Genet Evol; 2018 Aug; 62():151-159. PubMed ID: 29684709
[TBL] [Abstract][Full Text] [Related]
6. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
7. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
Blume A; Neubacher B; Thiem J; Peters T
Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
[TBL] [Abstract][Full Text] [Related]
8. The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
Chen Z; Marcé P; Resende R; Alzari PM; Frasch AC; van den Elsen JMH; Crennell SJ; Watts AG
Eur J Med Chem; 2018 Oct; 158():25-33. PubMed ID: 30199703
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
13. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and the effect of 1,2,3-triazole sialylmimetic neoglycoconjugates on Trypanosoma cruzi and its cell surface trans-sialidase.
Campo VL; Sesti-Costa R; Carneiro ZA; Silva JS; Schenkman S; Carvalho I
Bioorg Med Chem; 2012 Jan; 20(1):145-56. PubMed ID: 22154559
[TBL] [Abstract][Full Text] [Related]
15. A sialidase mutant displaying trans-sialidase activity.
Paris G; Ratier L; Amaya MF; Nguyen T; Alzari PM; Frasch AC
J Mol Biol; 2005 Jan; 345(4):923-34. PubMed ID: 15588836
[TBL] [Abstract][Full Text] [Related]
16. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
Dc-Rubin SS; Schenkman S
Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
[TBL] [Abstract][Full Text] [Related]
17. The trans-sialidase from Trypanosoma cruzi efficiently transfers alpha-(2-->3)-linked N-glycolylneuraminic acid to terminal beta-galactosyl units.
Agustí R; Giorgi ME; de Lederkremer RM
Carbohydr Res; 2007 Nov; 342(16):2465-9. PubMed ID: 17765882
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
Dias WB; Fajardo FD; Graça-Souza AV; Freire-de-Lima L; Vieira F; Girard MF; Bouteille B; Previato JO; Mendonça-Previato L; Todeschini AR
Cell Microbiol; 2008 Jan; 10(1):88-99. PubMed ID: 17672865
[TBL] [Abstract][Full Text] [Related]
19. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
[TBL] [Abstract][Full Text] [Related]
20. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation.
Mucci J; Risso MG; Leguizamón MS; Frasch AC; Campetella O
Cell Microbiol; 2006 Jul; 8(7):1086-95. PubMed ID: 16819962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
